PPD and DiabetesAmerica Enter Exclusive Partnership

Tuesday, December 22, 2009 07:37 AM

Wilmington, N.C.-based PPD has entered into an exclusive partnership with Houston, Texas-based DiabetesAmerica to provide clinical research training and support to the company’s 17 clinical trial centers across Texas and Arizona.

The contract research organization (CRO) will support more than 20 clinical trial investigators conducting type 1 and type 2 diabetes clinical trials. In return, DiabetesAmerica will work exclusively with PPD for a minimum of three years to provide clinical research services for endocrine and metabolic disease development programs. PPD will be able to recruit clinical trial participants from DiabetesAmerica’s 16,000-plus patient database.

"Diabetes is a disease with serious complications that affects more than 23 million Americans," said Mike Wilkinson, executive vice president of clinical development at PPD. "DiabetesAmerica's patient database expands our ability to offer clinical trial options to a broader population of people living with this increasingly common disease."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private á¼€nancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs